Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 2Other 1Gastrointestinal 1

Conditions

Stomatognathic Diseases 1Stomatitis 1Neoplasms by Site 1Neoplasms 1Mucositis 1Mouth Diseases 1Head and Neck Neoplasms 1Gastrointestinal Diseases 1Gastroenteritis 1Digestive System Diseases 1

Interventions

naloxegol 7alvimopan 6Radiotherapy 5angiotensin I (1-7) 4Cisplatin 4tegaserod 3Injections 3RRx-001 2Fibroblast Growth Factor 7 2tempol 1prucalopride 1oxycodone naloxone combination 1naldemedine 1methylnaltrexone 1linaclotide 1licogliflozin 1hydrated silica gel-based toothpaste 1golotimod 1brilacidin 1apraglutide 1amlexanox 1aluminum hydroxide, magnesium hydroxide, drug combination 1Xylitol 1Water 1Therapeutics 1Testosterone Propionate 1Robotic Surgical Procedures 1Radiotherapy, Intensity-Modulated 1Phenylephrine 1Oxycodone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × golotimod × Other × Clear all
NCT01247246 2014-05-26

Study to Evaluate the Efficacy and Safety of Three Different Doses of SCV 07 in Attenuating Oral Mucositis in Subjects With Head and Neck Cancer

SciClone Pharmaceuticals

Phase 2 Unknown
160 enrolled
GastrointestinalHead & NeckOther

Digestive System Diseases, Gastroenteritis, Gastrointestinal Diseases, Head and Neck Neoplasms, Stomatognathic Diseases, Mouth Diseases, Neoplasms, Neoplasms by Site, Stomatitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡